Cancer Vaccine Setback. Failed product is one of therapeutic cancer vaccines. Unlike typical vaccines given to healthy people to prevent disease, therapeutic cancer vaccines are given to patients already diagnosed with cancer
September 6, 2013 Leave a comment
September 5, 2013, 6:34 p.m. ET
Cancer Vaccine Setback
Failed Glaxo Trial Is Unlikely to Dampen Drug Firms’ Interest in Hot R&D Area
JEANNE WHALEN and RON WINSLOW
LONDON—An experimental cancer vaccine failed to help skin-cancer patients in aGlaxoSmithKline GSK.LN -0.81% PLC clinical trial, a setback for a hot area of medicine that seeks to harness the body’s immune system to fight tumors. When compared to a placebo, the vaccine, called MAGE-A3, didn’t increase the amount of time melanoma patients lived without their disease returning, Glaxo said Thursday. The 1,345 patients in the late-stage trial were given either the vaccine or a placebo after their tumors were surgically removed. Read more of this post







